Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Phosphaplatin Anti-tumor Effect Enhanced by Liposomes Partly via an Up-regulation of PEDF in Breast Cancer.

Belkacemi L, Atkins JL, Yang LU, Gadgil P, Sater AK, Chow DS, Bose RN, Zhang SX.

Anticancer Res. 2018 Feb;38(2):623-646.

PMID:
29374685
2.

Insights into the anti-angiogenic properties of phosphaplatins.

Yang L, Moghaddas S, Dezvareh H, Belkacemi L, Bark SJ, Bose RN, Do LH.

J Inorg Biochem. 2016 Nov;164:5-16. doi: 10.1016/j.jinorgbio.2016.07.020. Epub 2016 Jul 27.

PMID:
27591123
3.

Correlation between Gene Variants, Signaling Pathways, and Efficacy of Chemotherapy Drugs against Colon Cancers.

Tripathi S, Belkacemi L, Cheung MS, Bose RN.

Cancer Inform. 2016 Jan 20;15:1-13. doi: 10.4137/CIN.S34506. eCollection 2016.

4.

Absence of Activation of DNA Repair Genes and Excellent Efficacy of Phosphaplatins against Human Ovarian Cancers: Implications To Treat Resistant Cancers.

Bose RN, Moghaddas S, Belkacemi L, Tripathi S, Adams NR, Majmudar P, McCall K, Dezvareh H, Nislow C.

J Med Chem. 2015 Nov 12;58(21):8387-401. doi: 10.1021/acs.jmedchem.5b00732. Epub 2015 Oct 27.

PMID:
26455832
5.

Potentially deadly carcinogenic chromium redox cycle involving peroxochromium(IV) and glutathione.

Marin R, Ahuja Y, Bose RN.

J Am Chem Soc. 2010 Aug 11;132(31):10617-9. doi: 10.1021/ja102173v. Erratum in: J Am Chem Soc. 2011 Nov 2;133(43):17519.

PMID:
20681676
6.

Unwinding of zinc finger domain of DNA polymerase I by cis-diamminedichloroplatinum(II).

Maurmann L, Bose RN.

Dalton Trans. 2010 Sep 14;39(34):7968-79. doi: 10.1039/c0dt00274g. Epub 2010 Jul 29.

PMID:
20668765
7.

Non-DNA-binding platinum anticancer agents: Cytotoxic activities of platinum-phosphato complexes towards human ovarian cancer cells.

Bose RN, Maurmann L, Mishur RJ, Yasui L, Gupta S, Grayburn WS, Hofstetter H, Salley T.

Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18314-9. doi: 10.1073/pnas.0803094105. Epub 2008 Nov 19. Erratum in: Proc Natl Acad Sci U S A. 2009 Jan 27;106(4):1292. Milton, Tara [corrected to Salley, Tara].

8.

Synthesis, X-ray crystallographic, and NMR characterizations of platinum(II) and platinum(IV) pyrophosphato complexes.

Mishur RJ, Zheng C, Gilbert TM, Bose RN.

Inorg Chem. 2008 Sep 15;47(18):7972-82. doi: 10.1021/ic800237a. Epub 2008 Aug 9.

PMID:
18693681
9.

Insight into the reactive form of the anticancer agent iproplatin.

Volckova E, Weaver E, Bose RN.

Eur J Med Chem. 2008 May;43(5):1081-4. Epub 2007 Jul 10.

PMID:
17707553
10.

Mechanisms of DNA damage and insight into mutations by chromium(VI) in the presence of glutathione.

Mazzer PA, Maurmann L, Bose RN.

J Inorg Biochem. 2007 Jan;101(1):44-55. Epub 2006 Aug 30.

PMID:
17011629
11.

Nuclear magnetic resonance structures of the zinc finger domain of human DNA polymerase-alpha.

Evanics F, Maurmann L, Yang WW, Bose RN.

Biochim Biophys Acta. 2003 Sep 23;1651(1-2):163-71.

PMID:
14499601
12.
13.

Unwinding of DNA polymerases by the antitumor drug, cis-diamminedichloroplatinum(II).

Volckova E, Evanics F, Yang WW, Bose RN.

Chem Commun (Camb). 2003 May 21;(10):1128-9.

PMID:
12778700
14.

Biomolecular targets for platinum antitumor drugs.

Bose RN.

Mini Rev Med Chem. 2002 Apr;2(2):103-11. Review.

PMID:
12370072
15.

DNA oxidation by peroxo-chromium(v) species: oxidation of guanosine to guanidinohydantoin.

Joudah L, Moghaddas S, Bose RN.

Chem Commun (Camb). 2002 Aug 21;(16):1742-3.

PMID:
12196977

Supplemental Content

Loading ...
Support Center